baicalin has been researched along with Myocardial Ischemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Guo, X; Hu, C; Hu, S; Jiang, L; Luo, Y; Ma, S; Ma, X; Yan, Q; Yang, F; Yuan, L; Zeng, J; Zhou, C | 1 |
| Huang, A; Li, G; Liang, S; Lin, W; Liu, S; Peng, L; Song, M; Wen, S; Wu, B; Xie, Q; Xie, W; Xu, B; Xu, X; Zhang, J; Zhang, Z | 1 |
| Chen, C; He, Y; Huang, S; Lei, W; Lu, X; Shui, X; Su, W; Xue, Y; Yan, G; Zhang, Y | 1 |
| Pan, J; Wang, J; Zhang, S | 1 |
1 review(s) available for baicalin and Myocardial Ischemia
| Article | Year |
|---|---|
Evidence construction of baicalin for treating myocardial ischemia diseases: A preclinical meta-analysis.
Topics: Animals; Disease Models, Animal; Flavonoids; Glycosides; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury | 2022 |
3 other study(ies) available for baicalin and Myocardial Ischemia
| Article | Year |
|---|---|
Study of baicalin on sympathoexcitation induced by myocardial ischemia via P2X3 receptor in superior cervical ganglia.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Disease Models, Animal; Epinephrine; Flavonoids; Heart; Heart Rate; Injections, Intraperitoneal; Male; Myocardial Ischemia; Myocardium; Purinergic P2X Receptor Antagonists; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; RNA, Messenger; Superior Cervical Ganglion | 2015 |
Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor.
Topics: Animals; Anti-Inflammatory Agents; Basic Helix-Loop-Helix Transcription Factors; C-Reactive Protein; Disease Models, Animal; Flavonoids; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; Mice; Myocardial Ischemia; Myocarditis; Myocytes, Cardiac; Necrosis; Receptors, Aryl Hydrocarbon; Signal Transduction; Ventricular Remodeling | 2015 |
Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Topics: Animals; Biological Availability; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Emulsions; Flavonoids; Half-Life; Lipids; Male; Myocardial Ischemia; Nanoparticles; Particle Size; Polyethylene Glycols; Protective Agents; Rats; Rats, Sprague-Dawley; Solubility; Tissue Distribution | 2016 |